CDT-based fenofibrate tablets: Phase I/II started

DDD started an open-label, crossover, Canadian Phase I/II trial in 36 healthy adults. The trial will compare 3 formulations of immediate-release CDT-based fenofibrate tablets to Tricor fenofibrate 48...